Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance [Phase 4]

View source ↗

Summary

Phase 4 study assessing the safety and feasibility of testosterone replacement therapy in men with hypogonadism and prostate cancer under active surveillance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: University of Miami | Conditions: Prostate Cancer, Hypogonadism, Male | Phase 4 | Status: NOT_YET_RECRUITING